VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1564496
Sex: M
Age: 79
State: NC

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was sore; Arm was heavy; gets cold and can't get warm; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (gets cold and can't get warm), INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm was sore) and LIMB DISCOMFORT (Arm was heavy) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced NASOPHARYNGITIS (gets cold and can't get warm) and INFLUENZA LIKE ILLNESS (flu like symptoms). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was sore) and LIMB DISCOMFORT (Arm was heavy). At the time of the report, NASOPHARYNGITIS (gets cold and can't get warm), INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (arm was sore) and LIMB DISCOMFORT (Arm was heavy) outcome was unknown. Unknown Concomitant product use was not provided by the reporter. Treatment information was not provided. The action taken with mRNA in response to these events was not applicable.

Other Meds:

Current Illness:

ID: 1564497
Sex: F
Age: 41
State: CA

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left arm is very sore; Nauseous; Coughing; Back pain intensified; Felt bad all day; Fever; Muscles hurt; Joints hurt; Feeling dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling dizzy), COUGH (Coughing), BACK PAIN (Back pain intensified), PAIN IN EXTREMITY (Left arm is very sore) and FEELING ABNORMAL (Felt bad all day) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Back pain (She usually has back pain). On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (Feeling dizzy). On 09-Mar-2021, the patient experienced COUGH (Coughing), BACK PAIN (Back pain intensified), FEELING ABNORMAL (Felt bad all day), PYREXIA (Fever), MYALGIA (Muscles hurt) and ARTHRALGIA (Joints hurt). On an unknown date, the patient experienced PAIN IN EXTREMITY (Left arm is very sore) and NAUSEA (Nauseous). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Feeling dizzy), COUGH (Coughing), BACK PAIN (Back pain intensified), PAIN IN EXTREMITY (Left arm is very sore), FEELING ABNORMAL (Felt bad all day), PYREXIA (Fever), MYALGIA (Muscles hurt), ARTHRALGIA (Joints hurt) and NAUSEA (Nauseous) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness: Back pain (She usually has back pain)

ID: 1564498
Sex: F
Age: 76
State: MA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: couldn't move left leg or foot; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (couldn't move left leg or foot) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A211A) for COVID-19 vaccination. The patient's past medical history included Stroke (patient had stroke in 2017). Concomitant products included SIMVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication. On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced LIMB DISCOMFORT (couldn't move left leg or foot). At the time of the report, LIMB DISCOMFORT (couldn't move left leg or foot) outcome was unknown. Treatment drugs were not provided, Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds: SIMVASTATIN; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1564499
Sex: F
Age:
State: IL

Vax Date: 02/10/2021
Onset Date: 02/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Area near injection site had lumps (it was initially 2, but it got bigger and become one); Area near injection site was itchy; Area near injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Area near injection site had lumps (it was initially 2, but it got bigger and become one)), VACCINATION SITE PRURITUS (Area near injection site was itchy) and VACCINATION SITE ERYTHEMA (Area near injection site was red) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE MASS (Area near injection site had lumps (it was initially 2, but it got bigger and become one)), VACCINATION SITE PRURITUS (Area near injection site was itchy) and VACCINATION SITE ERYTHEMA (Area near injection site was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Area near injection site had lumps (it was initially 2, but it got bigger and become one)), VACCINATION SITE PRURITUS (Area near injection site was itchy) and VACCINATION SITE ERYTHEMA (Area near injection site was red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter.

Other Meds:

Current Illness:

ID: 1564500
Sex: M
Age: 93
State: MN

Vax Date: 12/30/2020
Onset Date: 01/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore Throat; Cough; Weakness; body aches; Fever; This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1564501
Sex: U
Age:
State:

Vax Date: 02/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever around 100 degrees; Body aches; Chills.; Still feel more lethargic at night; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever around 100 degrees), MYALGIA (Body aches), CHILLS (Chills.) and LETHARGY (Still feel more lethargic at night) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse reaction (No medical history reported). On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever around 100 degrees), MYALGIA (Body aches), CHILLS (Chills.) and LETHARGY (Still feel more lethargic at night). At the time of the report, PYREXIA (Fever around 100 degrees), MYALGIA (Body aches), CHILLS (Chills.) and LETHARGY (Still feel more lethargic at night) outcome was unknown. Not Provided

Other Meds:

Current Illness:

ID: 1564502
Sex: F
Age:
State: IN

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: skin was hot; feeling really cold; Little nauseated; Headache/felt pounding behind head and temple; muscle pain was unbearable; arm got real heavy and painful; pretty dizzy; pretty weak; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (pretty dizzy), ASTHENIA (pretty weak), PAIN IN EXTREMITY (arm got real heavy and painful), SKIN WARM (skin was hot) and FEELING COLD (feeling really cold) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Arthritis. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (pretty dizzy) and ASTHENIA (pretty weak). On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm got real heavy and painful). On an unknown date, the patient experienced SKIN WARM (skin was hot), FEELING COLD (feeling really cold), NAUSEA (Little nauseated), HEADACHE (Headache/felt pounding behind head and temple) and MYALGIA (muscle pain was unbearable). At the time of the report, DIZZINESS (pretty dizzy), ASTHENIA (pretty weak), PAIN IN EXTREMITY (arm got real heavy and painful), SKIN WARM (skin was hot), FEELING COLD (feeling really cold), NAUSEA (Little nauseated), HEADACHE (Headache/felt pounding behind head and temple) and MYALGIA (muscle pain was unbearable) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness: Arthritis

ID: 1564503
Sex: F
Age:
State: TX

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pounding headache; chills; high fever; She also got vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (pounding headache), CHILLS (chills), PYREXIA (high fever) and VOMITING (She also got vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced HEADACHE (pounding headache), CHILLS (chills), PYREXIA (high fever) and VOMITING (She also got vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (pounding headache), CHILLS (chills), PYREXIA (high fever) and VOMITING (She also got vomiting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications details were not reported by the reporter.

Other Meds:

Current Illness:

ID: 1564504
Sex: F
Age: 64
State: AZ

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm soon after vaccine for one day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm soon after vaccine for one day) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm soon after vaccine for one day). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 10-Mar-2021, VACCINATION SITE PAIN (sore arm soon after vaccine for one day) had resolved. Concomitant product use was not provided by the reporter. the patient administered with the second dose of vaccine she didn't experienced with sore arm and felt great. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up information received on 21-JUN-2021 contains non significant and no new information.

Other Meds:

Current Illness:

ID: 1564505
Sex: F
Age: 63
State: TX

Vax Date: 02/26/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site is red, itchy, and hot to touch; Injection site is red, itchy, and hot to touch; Injection site is red, itchy, and hot to touch; Rash near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is red, itchy, and hot to touch), VACCINATION SITE PRURITUS (Injection site is red, itchy, and hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red, itchy, and hot to touch) and VACCINATION SITE RASH (Rash near the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy (Consumer is allergic to penicillin products.). On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is red, itchy, and hot to touch), VACCINATION SITE PRURITUS (Injection site is red, itchy, and hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red, itchy, and hot to touch) and VACCINATION SITE RASH (Rash near the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site is red, itchy, and hot to touch), VACCINATION SITE PRURITUS (Injection site is red, itchy, and hot to touch), VACCINATION SITE ERYTHEMA (Injection site is red, itchy, and hot to touch) and VACCINATION SITE RASH (Rash near the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment medication included oral allergy medicine (unspecified).

Other Meds:

Current Illness: Penicillin allergy (Consumer is allergic to penicillin products.)

ID: 1564506
Sex: M
Age: 18
State: CA

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Migraine; RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY; VOMITING; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING). At the time of the report, MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) increased. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications are provided. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: TCR received on 21-Jun-2021 and contains no new information

Other Meds:

Current Illness:

ID: 1564507
Sex: U
Age:
State: CA

Vax Date:
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vial was used to vaccinate 9 patients and the 10th dose was not used to vaccinate a patient because it was not a complete dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT PACKAGING QUANTITY ISSUE (vial was used to vaccinate 9 patients and the 10th dose was not used to vaccinate a patient because it was not a complete dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRODUCT PACKAGING QUANTITY ISSUE (vial was used to vaccinate 9 patients and the 10th dose was not used to vaccinate a patient because it was not a complete dose). On 09-Mar-2021, PRODUCT PACKAGING QUANTITY ISSUE (vial was used to vaccinate 9 patients and the 10th dose was not used to vaccinate a patient because it was not a complete dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was provided by the reporter. No treatment medication was reported. The nurse reported that she drew only 9 doses out of a vial and the 10th dose was only 0.2ml instead of 0.5ml. She received the shipment on 18Feb2021 and has already dispense 80 of the 100 vials. Only this one vial has had this problem so far. She just called to report it.

Other Meds:

Current Illness:

ID: 1564508
Sex: F
Age: 66
State: AL

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling at injection site; Hot and sore at injection site; Redness at injection site; Hot and sore at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site). 19-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE WARMTH (Hot and sore at injection site) and VACCINATION SITE PAIN (Hot and sore at injection site) had resolved and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment details and concomitant medications are reported.. The patient developed swelling, redness and hotness at injection site on 19-Feb-2021, which remained for 3 days. Then it automatically subsided. Then one week after that it came again, redness and soreness. and it subsided after two or three days. and nowagain there is redness at the injection site.

Other Meds:

Current Illness:

ID: 1564509
Sex: F
Age:
State: NY

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 3 shots of vaccine; A spontaneous report was received from a nurse concerning a female patient of unknown age, who received an extra dose of Moderna's COVID-19 vaccine (mRNA-1273) . The patient's medical history was not provided by the reporter. Concomitant product use was not reported. On 09-mar-2021, the patient received the dose of mRNA-1273 (Lot number: 014M20A) for prophylaxis of COVID-19 infection. The patient was given with 3 shots of vaccine mistakenly/Extra dose administered. Treatment details for events was not provided Action taken with mRNA-1273 in response to the events was not applicable. The outcome of the events, extra dose received/3 shots of vaccine was considered to be recovered.; Reporter's Comments: This report refers to a case of extra dose administered for mRNA-1273, lot # 014M20A with no associated AEs.

Other Meds:

Current Illness:

ID: 1564510
Sex: F
Age:
State: CA

Vax Date: 01/28/1949
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: queasy stomach; fever; body aches; runs; sick as a dog; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick as a dog), FATIGUE (fatigue), ABDOMINAL DISCOMFORT (queasy stomach), PYREXIA (fever) and PAIN (body aches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011AZ1A and 062G20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 28-Jan-1949, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced ILLNESS (sick as a dog), FATIGUE (fatigue), PYREXIA (fever), PAIN (body aches) and DIARRHOEA (runs). On 08-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (queasy stomach). On 01-Mar-2021, ILLNESS (sick as a dog), PYREXIA (fever), PAIN (body aches) and DIARRHOEA (runs) had resolved. At the time of the report, FATIGUE (fatigue) and ABDOMINAL DISCOMFORT (queasy stomach) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details included Tylenol, Ginger, Hydrocortisone gel.

Other Meds:

Current Illness:

ID: 1564511
Sex: M
Age: 53
State: MO

Vax Date: 02/25/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Inflammation all over his body; Rash all over his body; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation all over his body) and RASH (Rash all over his body) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No medical history reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced INFLAMMATION (Inflammation all over his body) and RASH (Rash all over his body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency and FAMOTIDINE (PEPCID AC) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Inflammation all over his body) and RASH (Rash all over his body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product used included Statin.

Other Meds:

Current Illness:

ID: 1564512
Sex: M
Age: 71
State: FL

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm) and PYREXIA (Fever) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002b21a) for COVID-19 vaccination. Previously administered products included for an unreported indication: TETANUS VACCINE (Patient stated that on the 16th of Feb he had a tetanus injection.) on 16-Feb-2021. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in his arm). On 10-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness in his arm) and PYREXIA (Fever) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 101.5 degree f High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1564513
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. No relavant concomitant medications reported. No treatment information was provided. Action taken with mRNA-123 is not applicable. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1564514
Sex: M
Age: 63
State: TX

Vax Date: 02/13/2021
Onset Date: 02/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ongoing tendonitis or bruise "like" pain at injection site/dull burning pain in injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Ongoing tendonitis or bruise "like" pain at injection site/dull burning pain in injection site) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PAIN (Ongoing tendonitis or bruise "like" pain at injection site/dull burning pain in injection site). At the time of the report, VACCINATION SITE PAIN (Ongoing tendonitis or bruise "like" pain at injection site/dull burning pain in injection site) had not resolved. Concomitant product use was not provided by the reporter. Treatment information was not provided. Ona n unspecified date the patient received the second dose of mRNA-1273 (Moderna COVID-19 Vaccine) in right arm with no issues. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Initial additional included second dose information.

Other Meds:

Current Illness:

ID: 1564515
Sex: F
Age: 70
State: WA

Vax Date: 02/28/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: raises area on the arm, that looks like a bulls eye; Raised area itches like an allergic reaction; Raised area is red; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red). At the time of the report, RASH PAPULAR (raises area on the arm, that looks like a bulls eye), HYPERSENSITIVITY (Raised area itches like an allergic reaction) and VACCINATION SITE ERYTHEMA (Raised area is red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided. Treatment of these medications were not reported.

Other Meds:

Current Illness:

ID: 1564516
Sex: F
Age: 74
State: TX

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy; vaccination site is very red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE ERYTHEMA (vaccination site is very red) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1564517
Sex: M
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 16 year old received vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Company comment: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: Unknown) with no associated AEs.

Other Meds:

Current Illness:

ID: 1564518
Sex: F
Age: 73
State: OR

Vax Date: 02/07/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Elevated blood sugar levels; Tenderness at site of injection; Body ache from head to toe; A spontaneous report was received from a consumer who was a 73-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced elevated blood sugar levels, body ache from head to toe and tenderness at the site of injection. The patient's medical history included Type 1 Diabetes Mellitus, insulin dependent. Concomitant medications reported were rosuvastatin, losartan, levothyroxine and insulin. On 7 Mar 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 029A21A) intramuscularly for prophylaxis of COVID-19 infection. On 8 Mar 2021, the patient experienced elevated blood sugar levels. She reported that she was requiring triple the amount of her usual insulin dose. She felt her situation was very dangerous. Also, she reported tenderness at the site of injection and a body ache from head to toe. Treatment included Insulin for the elevated blood glucose and ice for the tender injection site. The patient received both scheduled doses of mRNA-1273, therefore, action taken with mRNA-1273 in response to the events was not applicable. The outcomes of events, elevated blood sugar levels, body ache from head to toe and tenderness at the site of injection, were considered unknown.; Reporter's Comments: The events were consistent with increased risk of complications associated with history of diabetes, confounded by elderly age of patient. Company assessed the events to be unlikely related to company product.

Other Meds: ROSUVASTATIN; LOSARTAN; LEVOTHYROXINE; INSULIN

Current Illness: Diabetes mellitus insulin-dependent

ID: 1564519
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weak / no energy; Palpitations; Feeling tired; Headachy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ATENOLOL, ESCITALOPRAM OXALATE (LEXAPRO), ATORVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weak / no energy), PALPITATIONS (Palpitations), FATIGUE (Feeling tired) and HEADACHE (Headachy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, COVID-19: negative negative Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ATENOLOL; LEXAPRO; ATORVASTATIN; SYNTHROID; OMEPRAZOLE

Current Illness:

ID: 1564520
Sex: M
Age:
State: TX

Vax Date: 03/01/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having trouble breathing; low grade fever; headache; Chills; sweat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included INSULIN and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced HYPERHIDROSIS (sweat) and CHILLS (Chills). On 07-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced DYSPNOEA (having trouble breathing) and PYREXIA (low grade fever). At the time of the report, HYPERHIDROSIS (sweat), DYSPNOEA (having trouble breathing), CHILLS (Chills), PYREXIA (low grade fever) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: INSULIN; PROZAC

Current Illness: Diabetes

ID: 1564521
Sex: F
Age: 58
State: KY

Vax Date: 02/01/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nose is stuffed up; headache; she had chills; Sweating a lot; Felt like her chest was on fire; felt weak; Shortness of breath; Felt hot and cold; Coughing so much it hurt; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension. Concomitant products included IBUPROFEN and GABAPENTIN for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced COUGH (Coughing so much it hurt) and FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold). On 08-Mar-2021, the patient experienced FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), HYPERHIDROSIS (Sweating a lot) and CHILLS (she had chills). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nose is stuffed up) and HEADACHE (headache). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COUGH (Coughing so much it hurt), FEELING HOT (Felt like her chest was on fire), ASTHENIA (felt weak), DYSPNOEA (Shortness of breath), FEELING OF BODY TEMPERATURE CHANGE (Felt hot and cold), HYPERHIDROSIS (Sweating a lot), NASAL CONGESTION (Nose is stuffed up), HEADACHE (headache) and CHILLS (she had chills) outcome was unknown. Unknown Concomitant medication also include hypertension pills. Action taken with mRNA-123 is not applicable.

Other Meds: IBUPROFEN; GABAPENTIN

Current Illness: Hypertension

ID: 1564522
Sex: F
Age: 17
State: TX

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 17 and a half years patient received first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. Concurrent medical conditions included Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose). On 04-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 and a half years patient received first dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Follow-up received on 31 Mar 2021 included the outcome of event Inappropriate age at vaccine administration was resolved on 4-Mar-2021; Sender's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273, lot # 027A21A with no associated AEs.

Other Meds: ALBUTEROL [SALBUTAMOL]

Current Illness: Asthma

ID: 1564523
Sex: F
Age: 89
State: PA

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weak; Light headed; Sweating bad; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad). At the time of the report, ASTHENIA (Weak), DIZZINESS (Light headed) and HYPERHIDROSIS (Sweating bad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1564524
Sex: F
Age: 39
State: FL

Vax Date: 03/01/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on side of mouth; Slight cough; Laryngitis; This spontaneous case was reported by an other health care professional and describes the occurrence of ORAL MUCOSAL ERUPTION (rash on side of mouth), COUGH (Slight cough) and LARYNGITIS (Laryngitis) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. Concurrent medical conditions included Food allergy (Banana), Allergy (Plant) and Drug allergy. In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COUGH (Slight cough) and LARYNGITIS (Laryngitis). On an unknown date, the patient experienced ORAL MUCOSAL ERUPTION (rash on side of mouth). At the time of the report, ORAL MUCOSAL ERUPTION (rash on side of mouth) had resolved and COUGH (Slight cough) and LARYNGITIS (Laryngitis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication reported . No treatment medication reported.

Other Meds:

Current Illness:

ID: 1564525
Sex: M
Age: 88
State: PA

Vax Date: 03/01/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pruritus; rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (pruritus) and RASH (rash all over body) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Varicella (history of chicken pox), Shingles (Patient had shingles injection two years ago.) and Open heart surgery (Heart surgery in 2005) in 2005. On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PRURITUS (pruritus) and RASH (rash all over body). At the time of the report, PRURITUS (pruritus) and RASH (rash all over body) outcome was unknown. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: No new information; Reporter's Comments: Crosslink: MOD21-050383 Patient calling back about paperwork he received in the mail from a prior adverse event he reported. Crosslinked case and updated contact information.

Other Meds:

Current Illness:

ID: 1564526
Sex: F
Age:
State: OH

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itches like crazy (rash); red(rash); rash all over body after 1st dose, on her chest, face, back and arms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itches like crazy (rash)), RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination. No medical history reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itches like crazy (rash)), RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (itches like crazy (rash)) had not resolved and RASH ERYTHEMATOUS (red(rash)) and RASH (rash all over body after 1st dose, on her chest, face, back and arms) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Non significant follow up received on 24-may-2021, event was ongoing.

Other Meds:

Current Illness:

ID: 1564527
Sex: F
Age: 78
State:

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscles in throat were tense; Face felt funny; This spontaneous case was reported by a patient and describes the occurrence of THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023m20a and 006321A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included LOVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID) and AMITRIPTYLINE for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny). At the time of the report, THROAT TIGHTNESS (Muscles in throat were tense) and FACIAL DISCOMFORT (Face felt funny) outcome was unknown. Not Provided Concomitant medications also included unspecified blood pressure medication. Treatment information was not provided. Action taken with mRNA-123 is not applicable. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: information regarding 2nd dose added. action taken was updated.

Other Meds: LOVASTATIN; SYNTHROID; AMITRIPTYLINE

Current Illness: Hypertension

ID: 1564528
Sex: F
Age:
State: GA

Vax Date: 03/06/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Limbs feel cold; Limbs were hurting; Feeling a little Chilly; Minor headache; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache). At the time of the report, PERIPHERAL COLDNESS (Limbs feel cold), PAIN IN EXTREMITY (Limbs were hurting), CHILLS (Feeling a little Chilly) and HEADACHE (Minor headache) outcome was unknown. No Concomitant medication were provided by the reporter. No treatment medication was provided by the reporter. Action taken with mRNA-123 is not applicable.

Other Meds:

Current Illness:

ID: 1564529
Sex: F
Age: 68
State: NC

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blister all over tongue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Blister all over tongue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister all over tongue). At the time of the report, ORAL MUCOSAL BLISTERING (Blister all over tongue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details included None. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1564530
Sex: F
Age: 49
State: CT

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for COVID-19; Horrible pain in her arm that did not let her move it, she could not rise her hand; Did not let her move it, she could not rise her hand; Nor sleep well; Fever in the mornings but not at night; Chills; She could not walk.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Nasal congestion (Congestion) on 04-Mar-2021, Anosmia (The patient can't smell well because of the congestion) on 04-Mar-2021 and Cough on 04-Mar-2021. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand), MOBILITY DECREASED (Did not let her move it, she could not rise her hand), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night). On 07-Mar-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, CHILLS (Chills), GAIT DISTURBANCE (She could not walk.), COVID-19 (Tested positive for COVID-19), INSOMNIA (Nor sleep well) and PYREXIA (Fever in the mornings but not at night) outcome was unknown and PAIN IN EXTREMITY (Horrible pain in her arm that did not let her move it, she could not rise her hand) and MOBILITY DECREASED (Did not let her move it, she could not rise her hand) was resolving. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature increased: 100.4 (Inconclusive) Reached a temperature of 100.4?F, then 99.4?F. On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment for the events included medicine for fever.

Other Meds:

Current Illness:

ID: 1564531
Sex: F
Age: 92
State: CT

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhea; gas; cramps; dehydrated,; being tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,) and FATIGUE (being tired) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Rheumatoid arthritis (which is controlled). Concomitant products included LEVOTHYROXINE for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information includes took something for diarrhea and drinking water.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1564532
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: eye pain after receiving the vaccine; on stop gastro-intestinal problems; arms itches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches). At the time of the report, EYE PAIN (eye pain after receiving the vaccine), ABDOMINAL DISCOMFORT (on stop gastro-intestinal problems) and PRURITUS (arms itches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1564533
Sex: M
Age:
State:

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen Tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWOLLEN TONGUE (Swollen Tongue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced SWOLLEN TONGUE (Swollen Tongue). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 16-Feb-2021, SWOLLEN TONGUE (Swollen Tongue) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment includes diphenhydramine hydrochloride (Benadryl ) and it helped to get the swelling down.

Other Meds:

Current Illness:

ID: 1564534
Sex: F
Age: 60
State: OH

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Anxiety; Rash increasing from 1' to 3" left arm; Fatigue; Stronger pain at injection site (LEFT); Pain at injection site (LEFT); Taste metal; Tongue ulcers; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DYSGEUSIA (Taste metal), TONGUE ULCERATION (Tongue ulcers) and VACCINATION SITE PAIN (Pain at injection site (LEFT)). On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)). On 08-Mar-2021, the patient experienced FATIGUE (Fatigue). On 09-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm). On an unknown date, the patient experienced ANXIETY (Anxiety). On 10-Mar-2021, DYSGEUSIA (Taste metal), VACCINATION SITE PAIN (Pain at injection site (LEFT)) and VACCINATION SITE PAIN (Stronger pain at injection site (LEFT)) had resolved. At the time of the report, TONGUE ULCERATION (Tongue ulcers), ANXIETY (Anxiety), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash increasing from 1' to 3" left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1564535
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: several cowerkers had side effects after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (several cowerkers had side effects after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (several cowerkers had side effects after vaccination). At the time of the report, ADVERSE EVENT (several cowerkers had side effects after vaccination) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Information about concomitant medications was not reported. No treatment information as provided. This case was linked to MOD21-049967 (E2B Linked Report). This case was linked to MOD21-049967 (E2B Linked Report).; Sender's Comments: MOD21-049967:

Other Meds:

Current Illness:

ID: 1564536
Sex: F
Age: 62
State: CO

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Vaccination site pain; little headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PAIN (Vaccination site pain) and HEADACHE (little headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment medicines include Tylenol for Pain relief.

Other Meds:

Current Illness:

ID: 1564537
Sex: F
Age: 74
State: OH

Vax Date: 01/30/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling under jaw bone the size of a golf ball; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling under jaw bone the size of a golf ball) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination. The patient's past medical history included Knee pain (bad knee) and Surgery (2 artificial hips). On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced SWELLING FACE (swelling under jaw bone the size of a golf ball). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and Manual therapy (Ice pack) for Swelling face. At the time of the report, SWELLING FACE (swelling under jaw bone the size of a golf ball) had not resolved. Unknown The action taken for m-RNA 1273 moderna COVID -19 vaccine was not applicable. No concomitant medications were provided Treatment therapy included ice pack. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up document received on 23-JUN-2021 and contains no new information.

Other Meds:

Current Illness:

ID: 1564538
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site reaction; Last two days "feeling bad; pain in left arm, heart area and ribs, bottom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom). At the time of the report, VACCINATION SITE REACTION (injection site reaction), FEELING ABNORMAL (Last two days "feeling bad) and MYALGIA (pain in left arm, heart area and ribs, bottom) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Normal. On an unknown date, Electrocardiogram: normal. On an unknown date, Urine analysis: Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. patient reported experienced no symptoms from his first dose of Moderna covid-19 vaccine but after 24 days he experienced injection site reaction, last two days "feeling bad", pain in left arm, heart area and ribs, bottom. He reported his GP ruled out any problem heart related stuff, yesterday took blood work, urinalysis and EKG and nothing came out.

Other Meds:

Current Illness:

ID: 1564539
Sex: M
Age: 78
State: MD

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweating for 1hs and 2hs in my sleep, like from my waist to my neck; Felt very tired, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) and FATIGUE (Felt very tired, fatigue) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Patient already had COVID-19 a couple of months ago, finished with it on December 7th or 8th.) in December 2020. Concurrent medical conditions included Hypertension. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (Felt very tired, fatigue). On 08-Mar-2021, the patient experienced HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck). On 06-Mar-2021, FATIGUE (Felt very tired, fatigue) had resolved. At the time of the report, HYPERHIDROSIS (sweating for 1hs and 2hs in my sleep, like from my waist to my neck) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1564540
Sex: F
Age:
State: TX

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Unable to lift anything more than 2-3 pounds with my left arm; Pain in left arm after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. No medical history was provided by the reporter. . Concomitant products included ATORVASTATIN, VORTIOXETINE and CALCITONIN for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot). On 06-Jan-2021, LIMB DISCOMFORT (Unable to lift anything more than 2-3 pounds with my left arm) and INJECTION SITE PAIN (Pain in left arm after the first shot) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. This case was linked to MOD21-049310 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 03-May-2021 contains non-significant information: updated reporter information

Other Meds: ATORVASTATIN; VORTIOXETINE; CALCITONIN

Current Illness:

ID: 1564541
Sex: F
Age: 69
State: NY

Vax Date: 03/02/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness around the injection site; Itchiness at the injection site; Warm to touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site). On 09-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Other concomitant products included medications for blood pressure and diabetes. Treatment information was not provided.

Other Meds:

Current Illness: Diabetes

ID: 1564542
Sex: F
Age: 58
State: MI

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; Nauseous; extreme headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseous), HEADACHE (extreme headache) and FATIGUE (fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. Concurrent medical conditions included Brain tumor (Experience regular headache). On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced NAUSEA (Nauseous) and HEADACHE (extreme headache). On 09-Mar-2021, the patient experienced FATIGUE (fatigue). At the time of the report, NAUSEA (Nauseous) outcome was unknown and HEADACHE (extreme headache) and FATIGUE (fatigue) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient states that her headache was extreme to an extent it dwarfed her tumor headache and it was different. On 10-Mar-2021, her headache and fatigue seemed to be improving. Concomitant medications were not reported. Treatment information in response to events was not provided.

Other Meds:

Current Illness: Brain tumor (Experience regular headache)

ID: 1564543
Sex: F
Age: 73
State: NC

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1564544
Sex: F
Age: 89
State: NY

Vax Date: 01/22/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Unable to get 2nd dose due to a snowstrom. More than 36 days have passed since first shot; A spontaneous report was received from a consumer concerning a 89-years-old female patient who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced unable to get 2nd dose due to a snowstorm. More than 36 days have passed since first shot/missed dose. The patient's medical history provided was not reported. No relevant concomitant medication was reported. On 22 Jan 2020, prior to onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. The patient was unable to get second dose scheduled on 19 Feb 2021, due to a snowstorm. The patient informed that more than 36 days passed since first dose. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the event unable to get 2nd dose due to a snowstorm. More than 36 days have passed since first shot was considered recovered.; Reporter's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot #unknown with no associated AEs.

Other Meds:

Current Illness:

ID: 1564545
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the injection site). At the time of the report, VACCINATION SITE PAIN (Pain in the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm